Ricardo Cruz Jr, MD | |
801 Massachusetts Ave, Crosstown 6b, Boston, MA 02118-2526 | |
(617) 414-5951 | |
(617) 414-9201 |
Full Name | Ricardo Cruz Jr |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Experience | 13 Years |
Location | 801 Massachusetts Ave, Boston, Massachusetts |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1902195571 | NPI | - | NPPES |
110098157A | Medicaid | MA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2083A0300X | Preventive Medicine - Addiction Medicine | 259191 (Massachusetts) | Secondary |
207R00000X | Internal Medicine | 259191 (Massachusetts) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Pathways Healthcare | Quincy, MA | Home health agency |
Boston Medical Center | Boston, MA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Evans Medical Foundation Inc | 7416946546 | 445 |
News Archive
Surgeons at the Cedars-Sinai Institute for Spinal Disorders describe in the August 1 issue of the journal Spine a minimally invasive approach that enables them to perform fusion surgery on the difficult-to-access upper lumbar region of the spine with a reduced risk of serious complications.
University at Buffalo researchers are creating a new and unusual "app" for the smart phone: tracking air pollution.
Sinovac Biotech Ltd. ( SVA), a leading developer and provider of vaccines, announced today that it has filed a shelf registration statement on Form F-3 with the U.S. Securities and Exchange Commission.
AstraZeneca today announced the outcome of the US Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee meeting to discuss the New Drug Application (NDA) for AstraZeneca's investigational drug, vandetanib, for the treatment of patients with unresectable (non-operable) locally advanced or metastatic medullary thyroid cancer (MTC).
› Verified 7 days ago
Entity Name | Dothouse Health Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1578514733 PECOS PAC ID: 8729991021 Enrollment ID: O20031112000264 |
News Archive
Surgeons at the Cedars-Sinai Institute for Spinal Disorders describe in the August 1 issue of the journal Spine a minimally invasive approach that enables them to perform fusion surgery on the difficult-to-access upper lumbar region of the spine with a reduced risk of serious complications.
University at Buffalo researchers are creating a new and unusual "app" for the smart phone: tracking air pollution.
Sinovac Biotech Ltd. ( SVA), a leading developer and provider of vaccines, announced today that it has filed a shelf registration statement on Form F-3 with the U.S. Securities and Exchange Commission.
AstraZeneca today announced the outcome of the US Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee meeting to discuss the New Drug Application (NDA) for AstraZeneca's investigational drug, vandetanib, for the treatment of patients with unresectable (non-operable) locally advanced or metastatic medullary thyroid cancer (MTC).
› Verified 7 days ago
Entity Name | Evans Medical Foundation Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1912954124 PECOS PAC ID: 7416946546 Enrollment ID: O20040512000397 |
News Archive
Surgeons at the Cedars-Sinai Institute for Spinal Disorders describe in the August 1 issue of the journal Spine a minimally invasive approach that enables them to perform fusion surgery on the difficult-to-access upper lumbar region of the spine with a reduced risk of serious complications.
University at Buffalo researchers are creating a new and unusual "app" for the smart phone: tracking air pollution.
Sinovac Biotech Ltd. ( SVA), a leading developer and provider of vaccines, announced today that it has filed a shelf registration statement on Form F-3 with the U.S. Securities and Exchange Commission.
AstraZeneca today announced the outcome of the US Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee meeting to discuss the New Drug Application (NDA) for AstraZeneca's investigational drug, vandetanib, for the treatment of patients with unresectable (non-operable) locally advanced or metastatic medullary thyroid cancer (MTC).
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Ricardo Cruz Jr, MD 801 Albany St Fl G, Boston, MA 02119-3791 Ph: () - | Ricardo Cruz Jr, MD 801 Massachusetts Ave, Crosstown 6b, Boston, MA 02118-2526 Ph: (617) 414-5951 |
News Archive
Surgeons at the Cedars-Sinai Institute for Spinal Disorders describe in the August 1 issue of the journal Spine a minimally invasive approach that enables them to perform fusion surgery on the difficult-to-access upper lumbar region of the spine with a reduced risk of serious complications.
University at Buffalo researchers are creating a new and unusual "app" for the smart phone: tracking air pollution.
Sinovac Biotech Ltd. ( SVA), a leading developer and provider of vaccines, announced today that it has filed a shelf registration statement on Form F-3 with the U.S. Securities and Exchange Commission.
AstraZeneca today announced the outcome of the US Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee meeting to discuss the New Drug Application (NDA) for AstraZeneca's investigational drug, vandetanib, for the treatment of patients with unresectable (non-operable) locally advanced or metastatic medullary thyroid cancer (MTC).
› Verified 7 days ago
Kaitlyn My-tu Lam, MBBS Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114 Phone: 617-724-7738 | |
Kui Toh Gerard Leong, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 55 Fruit Street, Massachusetts General Hospital, Boston, MA 02114 Phone: 617-726-8862 | |
Ruma Rajbhandari, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 75 Francis St, Boston, MA 02115 Phone: 617-525-6841 | |
Alaka Ray, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114 Phone: 617-726-2066 | |
Meghan E Sise, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114 Phone: 617-726-2862 | |
Aaron Dickstein, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 Washington St, Box 233, Boston, MA 02111 Phone: 617-636-5883 Fax: 617-636-9292 | |
Dr. Felicia Elizabeth Patch, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 801 Massachusetts Ave, Crosstown 2, Boston, MA 02118 Phone: 617-414-4376 Fax: 617-414-4676 |